Evidence map›Paper›PMID 41965642›Full record

ArticleBMC health services research2026

Increasing reach of cancer care: provider perspectives on the value and use of teleoncology.

Leah L Zullig, Abigail Shapiro, Madeleine R Eldridge, Christa Tumminello, Ivonne Guzman, Scott E Sherman, Danil Makarov, Daniel Becker, Vida Passero, Navid Dardashti and 2 more

Abstract read
In one paragraph

Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Leah L ZulligCenter of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Healthcare System, 411 West Chapel Hill Street, Suite 600, Durham, NC, 27701, USA. leah.zullig@duke.edu.
Abigail ShapiroCenter of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Healthcare System, 411 West Chapel Hill Street, Suite 600, Durham, NC, 27701, USA.
Madeleine R EldridgeCenter of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Healthcare System, 411 West Chapel Hill Street, Suite 600, Durham, NC, 27701, USA.
Christa TumminelloCenter of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Healthcare System, 411 West Chapel Hill Street, Suite 600, Durham, NC, 27701, USA.
Ivonne GuzmanCenter of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Healthcare System, 411 West Chapel Hill Street, Suite 600, Durham, NC, 27701, USA.
Scott E ShermanVA New York Harbor Healthcare System, New York, NY, USA.
Danil MakarovVA New York Harbor Healthcare System, New York, NY, USA.
Daniel BeckerVA New York Harbor Healthcare System, New York, NY, USA.
Vida PasseroUniversity of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Navid DardashtiVA New York Harbor Healthcare System, New York, NY, USA.
Michael J KelleyDuke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
Karen SteinhauserCenter of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Healthcare System, 411 West Chapel Hill Street, Suite 600, Durham, NC, 27701, USA.

Funding

NCI NIH HHS 1P50CA271358-01
6 · The paper itself

Abstract

purposeIn-person cancer care within the national Veterans Health Administration (VA) system is challenging for many Veterans due to issues including rurality, transportation, finances, proximity to subspecialists, and other factors. The National TeleOncology Service (NTO) is a clinical service that enables VA oncologists from across the country to provide services via telehealth to Veterans with cancer. We sought to understand NTO providers’ perspectives on the role of the NTO in providing cancer care to Veterans via telehealth. PATIENTS AND

methodsWe recruited NTO providers through their monthly office hours meeting for two focus groups held via Microsoft Teams in November 2023. We entered data from notes, transcripts, chats, and audio recordings into a matrix for analysis according to question topic and associated Consolidated Framework for Implementation Research domains. We used a rapid qualitative analysis approach.

resultsProviders (n = 23) widely agreed that NTO service provides valuable cancer care, particularly for Veterans facing in-person access issues across many phases of cancer treatment and survivorship. NTO services include multidisciplinary providers in patient calls and make it easier to include patient caregivers who may not be able to travel to appointments. Despite initial rapport building being somewhat challenging, providers still reported that NTO overall is of high value, particularly for rural Veterans utilizing VA-provided cancer care.

conclusionRemotely delivered cancer care is an important addition to cancer care services. This may be especially important for Veterans living in rural areas or far from needed cancer care services. VA providers offer an important perspective on the role of NTO in cancer care, the barriers they face to delivering that care, and the facilitators that VA can utilize to promote the success of NTO. In an era when Centers for Medicare & Medicaid Services (CMS) shifts away from reimbursing telehealth, the VA has committed to continue such care providing a variety of patient-centered approaches.

Indexed as

Attitude of Health PersonnelMedical OncologyNeoplasmsTelemedicineFemaleFocus GroupsHealth Services AccessibilityHumansMaleQualitative ResearchUnited StatesUnited States Department of Veterans AffairsVeteransCare qualityHealth services researchTelehealthVeterans health

Identifiers

PMID41965642
PMCPMC13196161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.